Lester P, Kohen I, Stefanacci RG, et al. Antipsychotic drug use since the FDA black box warning: survey of nursing home policies. J Am Med Dir Assoc 2011;12:573-7.Lester P, Kohen I, Stefanacci RG, Feuerman M. Antipsychotic drug use since the FDA black box warning: survey of ...
The 2005 US Food and Drug Administration (FDA) black-box warning about increased mortality being linked to atypical antipsychotic (AAP) use in elderly patients with dementia may have had unintended consequences. However, at this point, the findings are "hypothesis generating," and more research is...
BACKGROUND: In April 2005, the US Food and Drug Administration (FDA) issued an advisory and subsequent black box warning regarding the risks of atypical anti psychotic use among elderly patients with dementia. The impact of these warnings on atypical drug use is unknown. METHODS: We used quasi...
"The drugging of nursing home residents has long been a national disgrace," she said, adding that hundreds of thousands of long-term care residents are drugged inappropriately, costing hundreds of millions of dollars. These drugs carry a black box warning from the U.S.Food and Drug Administrati...
symptoms of dementia (BPSD) CMS initiative is to safely: Optimize the quality of life andfunction of nursing From the required Black Box Warning: Increased the ability of caretakers todetect and address the true underlying need." From his book "Dementia Beyond Drugs"A Antipsychotic, J Deri, ...
Impact of the Food and Drug Administration's antipsychotic black box warning on psychotropic drug prescribing in elderly patients with dementia in outpatie... Most patients with dementia also suffer from behavioral and psychological symptoms of dementia, for which there is no Food and Drug Administra...
6 In 2005, the FDA issued a black box warning and health advi- sory on the use of atypical antipsychotic medications in the treatment of behavioral ... Small,W Gary - 《Journal of the American Medical Association》 被引量: 16发表: 2014年 Effect of an interdisciplinary educational program ...
The rate of decline in the use of atypical antipsychotics in outpatients with dementia accelerated following a black box warning issued by FDA, according todoi:http://drugtopics.modernmedicine.com/node/152868From Ora Staff ReportsAdvanstar Communications Inc...
In April 2005, the Food and Drug Administration (FDA) issued a black box warning (BBW) regarding the risks of using atypical antipsychotics (AAPs) for behavioral disorders in elderly patients with dementia. The objective of the present study was to investigate the impact of the BBW on the ...
Impact of the Food and Drug Administration's antipsychotic black box warning on psychotropic drug prescribing in elderly patients with dementia in outpatient and office-based settings. Alzheimer's & Dementia. 2012;8:453-7.V.C. Desai, P.C. Heaton, and C.M. Kelton, "Impact of the Food and...